Julia Kargl

4.4k total citations
62 papers, 3.0k citations indexed

About

Julia Kargl is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Julia Kargl has authored 62 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 18 papers in Oncology and 17 papers in Molecular Biology. Recurrent topics in Julia Kargl's work include Cannabis and Cannabinoid Research (14 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Immune cells in cancer (12 papers). Julia Kargl is often cited by papers focused on Cannabis and Cannabinoid Research (14 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Immune cells in cancer (12 papers). Julia Kargl collaborates with scholars based in Austria, United States and United Kingdom. Julia Kargl's co-authors include A. McGarry Houghton, Maria Waldhoer, Nariman Balenga, Ákos Heinemann, Heather Metz, Mark L. Hanke, Rudolf Schicho, Stephanie Busch, Andrew J. Brown and Wolfgang Platzer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Julia Kargl

60 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Kargl Austria 28 1.1k 958 886 707 434 62 3.0k
Mohd W. Nasser United States 35 752 0.7× 1.7k 1.8× 983 1.1× 593 0.8× 387 0.9× 72 3.5k
Graziano Pelli Switzerland 32 1.5k 1.4× 1.1k 1.1× 624 0.7× 593 0.8× 185 0.4× 52 3.5k
Lily Lu United States 17 1.6k 1.5× 557 0.6× 931 1.1× 468 0.7× 103 0.2× 25 2.8k
Akira Hashiramoto Japan 27 646 0.6× 1.5k 1.5× 488 0.6× 976 1.4× 154 0.4× 71 3.5k
Linda S. Higgins United States 34 395 0.4× 2.1k 2.2× 1.1k 1.2× 315 0.4× 552 1.3× 66 4.0k
Alessandro Alessandrini United States 32 759 0.7× 2.7k 2.9× 699 0.8× 165 0.2× 174 0.4× 56 4.6k
Vincent Sauzeau France 27 336 0.3× 1.8k 1.9× 271 0.3× 230 0.3× 358 0.8× 51 3.3k
Yoshiki Iwamoto Japan 25 718 0.7× 984 1.0× 1.1k 1.2× 145 0.2× 139 0.3× 53 3.1k
Naonori Uozumi Japan 23 500 0.5× 1.4k 1.4× 230 0.3× 415 0.6× 288 0.7× 34 2.6k
Clara Nahmias France 35 283 0.3× 2.0k 2.0× 483 0.5× 186 0.3× 329 0.8× 73 3.5k

Countries citing papers authored by Julia Kargl

Since Specialization
Citations

This map shows the geographic impact of Julia Kargl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Kargl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Kargl more than expected).

Fields of papers citing papers by Julia Kargl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Kargl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Kargl. The network helps show where Julia Kargl may publish in the future.

Co-authorship network of co-authors of Julia Kargl

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Kargl. A scholar is included among the top collaborators of Julia Kargl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Kargl. Julia Kargl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Runtsch, Marah C., Stefano Angiari, & Julia Kargl. (2025). Targeting myeloid cell immunometabolism to improve current non-small cell lung cancer therapies. Pharmacology & Therapeutics. 273. 108893–108893. 2 indexed citations
2.
Wernitznig, Stefan, Amin El‐Heliebi, Julia Kargl, et al.. (2024). The chicken chorioallantoic membrane assay revisited – A face-lifted approach for new perspectives in placenta research. Placenta. 166. 77–84.
3.
Kienzl, Melanie, et al.. (2024). Comparative Study of the Immune Microenvironment in Heterotopic Tumor Models. Cancers. 16(2). 295–295. 4 indexed citations
4.
Stadler, Julia T., Hansjörg Habisch, Florian Prüller, et al.. (2023). HDL-Related Parameters and COVID-19 Mortality: The Importance of HDL Function. Antioxidants. 12(11). 2009–2009. 11 indexed citations
5.
Vondra, Sigrid, Johanna Raffetseder, Andrea Vogel, et al.. (2023). The human placenta shapes the phenotype of decidual macrophages. Cell Reports. 42(1). 111977–111977. 21 indexed citations
6.
Valadez-Cosmes, Paulina, Marah C. Runtsch, Melanie Kienzl, et al.. (2023). Myeloperoxidase Alters Lung Cancer Cell Function to Benefit Their Survival. Antioxidants. 12(8). 1587–1587. 6 indexed citations
7.
Kienzl, Melanie, Carina Hasenoehrl, Ulrike Taschler, et al.. (2023). Tumor microenvironment-derived monoacylglycerol lipase provokes tumor-specific immune responses and lipid profiles. Prostaglandins Leukotrienes and Essential Fatty Acids. 196. 102585–102585. 1 indexed citations
8.
Marsche, Gunther, Julia T. Stadler, Julia Kargl, & Michael Holzer. (2022). Understanding Myeloperoxidase-Induced Damage to HDL Structure and Function in the Vessel Wall: Implications for HDL-Based Therapies. Antioxidants. 11(3). 556–556. 17 indexed citations
9.
Markert, Udo R., P Reif, W Schoell, et al.. (2022). The fate of human SUSD2+ endometrial mesenchymal stem cells during decidualization. Stem Cell Research. 60. 102671–102671. 9 indexed citations
10.
Barth, Dominik A., Stefanie Stanzer, Thomas Bauernhofer, et al.. (2022). Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study. Frontiers in Immunology. 13. 840207–840207. 18 indexed citations
11.
Kienzl, Melanie, Carina Hasenoehrl, Ulrike Taschler, et al.. (2021). Monoacylglycerol lipase deficiency in the tumor microenvironment slows tumor growth in non-small cell lung cancer. OncoImmunology. 10(1). 1965319–1965319. 20 indexed citations
12.
Uhl, Barbara, Jelena Krstić, Karoline Fechter, et al.. (2021). Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions. International Journal of Molecular Sciences. 22(24). 13311–13311. 75 indexed citations
13.
Veatch, Joshua, Julia Kargl, Matthew Fitzgibbon, et al.. (2019). Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic KRAS and ERBB2 ( Her2 ) Driver Mutations. Cancer Immunology Research. 7(6). 910–922. 70 indexed citations
14.
Kargl, Julia, Xiaodong Zhu, Huajia Zhang, et al.. (2019). Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC. JCI Insight. 4(24). 127 indexed citations
15.
Hassan, Ahmed M., Paulina Valadez-Cosmes, Aitak Farzi, et al.. (2019). Experimental colitis reduces microglial cell activation in the mouse brain without affecting microglial cell numbers. Scientific Reports. 9(1). 20217–20217. 30 indexed citations
16.
Lastwika, Kristin J., Julia Kargl, Yuzheng Zhang, et al.. (2018). Tumor-derived Autoantibodies Identify Malignant Pulmonary Nodules. American Journal of Respiratory and Critical Care Medicine. 199(10). 1257–1266. 25 indexed citations
17.
Grill, Magdalena, Carina Hasenoehrl, Melanie Kienzl, Julia Kargl, & Rudolf Schicho. (2018). Cellular localization and regulation of receptors and enzymes of the endocannabinoid system in intestinal and systemic inflammation. Histochemistry and Cell Biology. 151(1). 5–20. 24 indexed citations
18.
Mark, Nicholas M., Julia Kargl, Stephanie Busch, et al.. (2017). Chronic Obstructive Pulmonary Disease Alters Immune Cell Composition and Immune Checkpoint Inhibitor Efficacy in Non–Small Cell Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 197(3). 325–336. 82 indexed citations
19.
Balenga, Nariman, Christopher M. Henstridge, Julia Kargl, & Maria Waldhoer. (2011). Pharmacology, Signaling and Physiological Relevance of the G Protein-coupled Receptor 55. Advances in pharmacology. 62. 251–277. 27 indexed citations
20.
Henstridge, Christopher M., Nariman Balenga, R Schröder, et al.. (2010). GPR55 ligands promote receptor coupling to multiple signalling pathways. British Journal of Pharmacology. 160(3). 604–614. 171 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohd W. Nasser Breakdown of academic impact, for papers by Graziano Pelli Breakdown of academic impact, for papers by Lily Lu Breakdown of academic impact, for papers by Akira Hashiramoto Breakdown of academic impact, for papers by Linda S. Higgins Breakdown of academic impact, for papers by Alessandro Alessandrini Breakdown of academic impact, for papers by Vincent Sauzeau Breakdown of academic impact, for papers by Yoshiki Iwamoto Breakdown of academic impact, for papers by Naonori Uozumi Breakdown of academic impact, for papers by Clara Nahmias
Rankless by CCL
2026